Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OXTR | P30559 | 13/20 | 0.86 |
| ▸ | AVPR1A | P37288 | 8/20 | 0.86 |
| ▸ | AVPR2 | P30518 | 7/20 | 0.86 |
| ▸ | AVPR1B | P47901 | 7/20 | 0.86 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.76 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Argiprestocin SCHEMBL30424966 | 1.00 | OXTR (0.86) | OXTRAVPR1AAVPR2AVPR1BPTGS1 | |
| Vasotocin SCHEMBL15511393 | 1.00 | OXTR (0.86) | OXTRAVPR1AAVPR2AVPR1BPTGS1 | |
| Vasotocin SCHEMBL15511347 | 1.00 | OXTR (0.86) | OXTRAVPR1AAVPR2AVPR1BPTGS1 | |
| SCHEMBL15511428 | 0.97 | OXTR (0.82) | OXTRAVPR1AAVPR2AVPR1BPTGS1 | |
| SCHEMBL29618038 | 0.94 | OXTR (0.86) | OXTRAVPR1AAVPR2AVPR1BPTGS1 | |
| SCHEMBL15511015 | 0.94 | OXTR (0.86) | OXTRAVPR1AAVPR2AVPR1B | |
| Desmopressin SCHEMBL28867243 | 0.93 | OXTR (0.82) | OXTRAVPR1AAVPR2AVPR1BPTGS1 | |
| Vasopressin SCHEMBL29688276 | 0.92 | AVPR1A (1.00) | OXTRAVPR1AAVPR2AVPR1BPTGS1 | |
| Vasopressin SCHEMBL18937546 | 0.92 | AVPR1A (1.00) | OXTRAVPR1AAVPR2AVPR1BPTGS1 | |
| Vasopressin SCHEMBL19712236 | 0.92 | AVPR1A (1.00) | OXTRAVPR1AAVPR2AVPR1BPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 56302 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026107133-A1 | NEURAL NETWORK AUTOMATED INVASIVE ARTERIAL PRESSURE EXTRACTION | REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2026-05-21 | — | — | WO | claimed |
| US-20260142033-A1 | NEURAL NETWORK AUTOMATED INVASIVE ARTERIAL PRESSURE EXTRACTION | REGENTS OF THE UNIV OF MICHIGAN (US) | 2026-05-21 | — | — | US | claimed |
| WO-2026099249-A1 | MODIFIED AND UNMODIFIED PEPTIDYLGLYCINE ALPHA-AMIDATING MONOOXYGENASE (PAM) FOR USE IN SUBJECTS HAVING INCREASED AMYLOID-BETA AND/OR PHOSPHO-TAU-PROTEIN LOAD AND/OR NEUROINFLAMMATION | PAM THERAGNOSTICS GMBH (DE) | 2026-05-15 | — | — | WO | claimed |
| EP-4739283-A1 | PEPTIDE STEREOCOMPLEXATION WITH BIODEGRADABLE STEREOREGULAR POLYESTERS IN WATER AND HYDROGEL FORMS THEREOF | Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. (IL) | 2026-05-13 | — | — | EP | claimed |
| CN-116744935-B | Benzazepine compound, preparation method and medical application thereof | 福建盛迪医药有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-20260124148-A1 | POLYPEPTIDE FORMULATIONS FOR ORAL DELIVERY | BHAMIS RES LABORATORY PVT LTD (IN) | 2026-05-07 | — | — | US | claimed |
| US-20260115299-A1 | CALSEQUESTRIN-BASED METAL ION REACTIVE PARTICLE AND USES THEREOF | TOOLBIO CO LTD (KR) | 2026-04-30 | — | — | US | claimed |
| EP-4731644-A1 | GLYCATED PROTEINS | Pnuvax, Inc. (CA) | 2026-04-29 | — | — | EP | claimed |
| EP-4732908-A2 | CANCER TREATMENT USING COMBINATIONS OF ERK AND RAF INHIBITORS | Biomed Valley Discoveries, Inc. (US) | 2026-04-29 | — | — | EP | claimed |
| US-12606797-B2 | Methods of detection of mechanically-activated platelet activation and uses thereof | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2026-04-21 | — | — | US | claimed |
| US-4377573-A | Method of control of gastrointestinal bleeding | DEVICE DEVELOPMENTS, INC. | 1983-03-22 | — | — | US | claimed |
| EP-0061356-A2 | Antagonists of the antidiuretic and/or vasopressor action of arginine vasopressin | Medical College of Ohio (US) | 1982-09-29 | — | — | EP | claimed |
| EP-0037516-A1 | N-omega substituted derivatives of 1-Desamino-vasopressin analogs | VEGA LABORATORIES, INC. (US) | 1981-10-14 | — | — | EP | claimed |
| US-4285858-A | ANTIHEMOPHILIC FACTOR; HEMOSTATIC AGENTS; ANTICOAGULANTS AND COAGULANTS | MT. SINAI SCHOOL OF MEDICINE OF THE CITY UNIVERSITY OF N.Y. (US) | 1981-08-25 | — | — | US | claimed |
| EP-0029659-A2 | Vasopressin analogs, processes for their production and a method of treating mammals | Cort, Joseph H. (US) | 1981-06-03 | — | — | EP | claimed |
| US-4216141-A | OXIDATION OF CYSTEINE RESIDUES TO FORM DISULFIDE BOND | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 1980-08-05 | — | — | US | claimed |
| EP-0010587-A1 | Adamantylalkyloxy-carbonyl derivatives, their preparation and their use for the production of peptides | Kalbacher, Hubert (DE) | 1980-05-14 | — | — | EP | claimed |
| US-4150149-A | RADIOIMMUNOASSAY, QUANTITATIVE ANALYSIS | PROFESSIONAL STAFF ASSOCIATION OF THE LOS ANGELES COUNTY HARBOR GENERAL HOSPITAL (US) | 1979-04-17 | — | — | US | claimed |
| US-4148787-A | CYCLIC POLYPEPTIDE | FERRING AB (SE) | 1979-04-10 | — | — | US | claimed |
| US-4033940-A | TERMINAL CYSTINE, REARRANGEMENT TO CYCLIC DISULFIDE | ARMOUR PHARMACEUTICAL COMPANY (US) | 1977-07-05 | — | — | US | claimed |